Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Gamma Biosciences Acquires Controlling Stake in Mirus Bio
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced that […]
Grand Rounds and Doctor On Demand to Merge, Creating First of its Kind Patient-Centric Integrated Virtual Healthcare Company
Grand Rounds, a leader in healthcare quality and navigation, and Doctor On Demand, the nation’s […]
Exelixis Acquires GamaMabs AMHR2
Exelixis, Inc. (Nasdaq: EXEL) and GamaMabs Pharma SA today announced that they have entered into an […]
Clean Biologics SAS acquires Biodextris Inc.
Clean Biologics, a group providing services to the biopharmaceutical industry, today announces the acquisition of […]
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology
ERT, a global leader in clinical endpoint data solutions, today announced the close of its […]
Holmusk Acquires Mental Health Analytics Provider Otsuka Health Solutions to Expand its Footprint in the UK
Holmusk, a leading global data science and digital health company building the world’s largest Real-World […]
Microsoft Accelerates Industry Cloud Strategy for Healthcare with the Acquisition of Nuance
Microsoft Corp and Nuance Communications, Inc. today announced they have entered into a definitive agreement […]
KD Pharma Group Acquires Phytoextract and CBD Manufacturing Assets
The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The […]
Sanofi Acquires Tidal Therapeutics
Sanofi today acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a novel […]
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
Eloxx Pharmaceuticals, Inc. today announced it has acquired Zikani Therapeutics, Inc. in an all-stock transaction, with […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more